We are live on
!
Find out more
GWCM
Godshalk Welsh Capital Management Portfolio holdings
AUM
$172M
1-Year Est. Return
16.03%
This Fund
S&P 500
This Quarter
Est. Return
+3.62%
1 Year Est. Return
+16.03%
3 Year Est. Return
+54.69%
5 Year Est. Return
+73.83%
10 Year Est. Return
+285.52%
AUM
$142M
AUM Growth
+$4.56M
(+3.3%)
Cap. Flow
+$1.67M
Cap. Flow
% of AUM
1.18%
Top 10 Holdings %
Top 10 Hldgs %
29.33%
Holding
119
New
6
Increased
27
Reduced
45
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WOW
WideOpenWest
WOW
|
+$933K |
| 2 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$449K |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$321K |
| 4 |
Fidelity High Dividend ETF
FDVV
|
+$294K |
| 5 |
Citigroup
C
|
+$221K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$275K |
| 2 |
Honeywell
HON
|
+$220K |
| 3 |
Microsoft
MSFT
|
+$156K |
| 4 |
Invesco Preferred ETF
PGX
|
+$126K |
| 5 |
Apple
AAPL
|
+$107K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.48% |
| 2 | Healthcare | 13.36% |
| 3 | Consumer Staples | 11.74% |
| 4 | Financials | 10.95% |
| 5 | Consumer Discretionary | 6.93% |
Similar funds
TA
CRFG
BAM
RPSM
MC
BIA
SPF
KIM
Godshalk Welsh Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Godshalk Welsh Capital Management held 119 positions worth $142M, up 3.3% from $137M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Godshalk Welsh Capital Management's Q1 2023 filing shows 6 new, 27 increased, 45 reduced and 1 closed positions. Its largest new stake was iShares Short-Term National Muni Bond ETF: 4,300 shares worth $450K. The largest sale was Pfizer, an estimated $275K.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Staples.
- Godshalk Welsh Capital Management's largest Q1 2023 buy was iShares Short-Term National Muni Bond ETF: 4,300 shares worth $450K.
- Godshalk Welsh Capital Management added most to WideOpenWest in Q1 2023, an estimated $933K increase.
- Godshalk Welsh Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $275K.
- Godshalk Welsh Capital Management fully exited Honeywell in Q1 2023, selling an estimated $220K.
- Godshalk Welsh Capital Management's ten largest holdings make up 29% of its $142M portfolio in Q1 2023.
- Godshalk Welsh Capital Management opened 6 new positions and closed 1 in Q1 2023.
- Godshalk Welsh Capital Management's portfolio value rose 3.3% quarter-over-quarter to $142M.
Based on Godshalk Welsh Capital Management's 13F filing for Q1 2023, filed 12 May 2023.